Will gene therapy cure fibrosis?
Updated: Oct 5
Gene therapy shows significant promise in the treatment of fibrosis by targeting key genes, particularly TGF-β1 (transforming growth factor-beta 1), which is crucial in driving excessive scar tissue formation. Innovative techniques, such as CRISPR-Cas9, are being utilized to modify or silence the TGF-β1 gene, potentially reducing or even halting the fibrotic process.
Additionally, stem cell-based gene therapy is emerging as a strategy to regenerate healthy tissue in fibrotic areas. Adeno-associated viruses (AAVs) serve as effective vectors to deliver these genetic modifications to affected cells. Although these therapies are still in experimental stages, they provide hope for curing fibrosis by addressing the genetic drivers of this debilitating condition.
Got more to add on this topic? Share your thoughts in the comments below!
Keep exploring with Gene Tech Times
Free guide: subscribe to the Gene Tech Times Briefing on our homepage and get Every FDA-Approved Gene Therapy at a Glance in your inbox.
Watch: 30-second gene therapy Shorts on Gene Tech Times Academy.
Read: The Cheat Codes of Our Genes, real stories of mutations that make some people immune to disease.
New to gene therapy? Start with The Life-Changing Power of Gene Therapy.
As an Amazon Associate, Gene Tech Times earns from qualifying purchases.
Comments